L3VLUP
ProSign in

SNN · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

SNNVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • SNN
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterSNNVRTX
Q3 20201 holders, $37m31 holders, $21.9bn
Q4 20202 holders, $36m30 holders, $18.4bn
Q1 2021none listed holders, n.a.31 holders, $15.4bn
Q2 20213 holders, $22m30 holders, $12.7bn
Q3 20212 holders, $8.7m35 holders, $10.1bn
Q4 20212 holders, $16m28 holders, $12.4bn
Q1 20222 holders, $31m23 holders, $16.1bn
Q2 20222 holders, $51m25 holders, $18.1bn
Q3 20223 holders, $54m22 holders, $18.4bn
Q4 20224 holders, $125m28 holders, $18.4bn
Q1 20232 holders, $75m26 holders, $21.4bn
Q2 20232 holders, $57m27 holders, $24.7bn
Q3 20231 holders, $31m33 holders, $24.3bn
Q4 20231 holders, $19m32 holders, $28.6bn
Q1 2024none listed holders, n.a.31 holders, $29.8bn
Q2 20241 holders, $3.4m29 holders, $33.4bn
Q3 20242 holders, $5.0m27 holders, $33.5bn
Q4 20242 holders, $88m26 holders, $28.5bn
Q1 20251 holders, $1.9m21 holders, $35.4bn
Q2 20251 holders, $2.4m21 holders, $32.3bn
Q3 20252 holders, $14m22 holders, $25.9bn
Q4 20251 holders, $10m26 holders, $31.8bn
Q1 20261 holders, $8.8m25 holders, $31.8bn
Q2 20262 holders, $9.3m26 holders, $34.6bn
SNN

Smith & Nephew PLC

Holders
1
Reported value
$8.8m
Buyers
7
Sellers
8

Breadth -1 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
VRTX

Vertex Pharmaceuticals Inc

Holders
25
Reported value
$31.8bn
Buyers
17
Sellers
21

Breadth -4 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2026

Among the 25 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only SNN (0)

None.

Only VRTX (24)

Acadian Asset Management LLC, AllianceBernstein LP, Arrowstreet Capital LP, Baillie Gifford & Co, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, D. E. Shaw & Co., ExodusPoint Capital Management LP, Fidelity (FMR LLC), Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Two Sigma Investments LP, Walleye Capital LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →